• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成骨细胞对作为骨植入材料的氧化铝-钛复合材料的反应。

Osteoblastic cell response to AlO-Ti composites as bone implant materials.

作者信息

Bahraminasab Marjan, Arab Samaneh, Ghaffari Somaye

机构信息

Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.

Department of Tissue Engineering and Applied Cell Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.

出版信息

Bioimpacts. 2022;12(3):247-259. doi: 10.34172/bi.2021.2330. Epub 2021 Sep 25.

DOI:10.34172/bi.2021.2330
PMID:35677667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9124877/
Abstract

Alumina-titanium (AlO-Ti) composites with enhanced mechanical and corrosion properties have been recently developed for potential applications in orthopaedics and hard tissue replacements. However, before any clinical use, their interactions with biological environment must be examined. The aim of this study, therefore, was to assess the biocompatibility of three AlO-Ti composites having 25, 50, and 75 volume percentages of titanium. These materials were made by spark plasma sintering (SPS), and MC3T3-E1 cells were cultured onto the sample discs to evaluate the cell viability, proliferation, differentiation, mineralization, and adhesion. Furthermore, the apatite formation ability and wettability of the composites were analysed. Pure Ti (100Ti) and monolithic AlO (0Ti) were also fabricated by SPS and biological characteristics of the composites were compared with them. The results showed that cell viability to 75Ti (95.0%), 50Ti (87.3%), and 25Ti (63.9%) was superior when compared with 100Ti (42.7%). Pure AlO also caused very high cell viability (89.9%). Furthermore, high cell proliferation was seen at early stage for 50Ti, while the cells exposed to 75Ti proliferated more at late stages. Cell differentiation was approximately equal between different groups, and increased by time. Matrix mineralization was higher on the composite surfaces rather than on 0Ti and 100Ti. Moreover, the cells adhered differently to the surfaces of different biomaterials where more spindle-shaped configuration was found on 100Ti, slightly enlarged cells with dendritic shape and early pseudopodia were observed on 75Ti, and more enlarged cells with long dendritic extensions were found on 0Ti, 25Ti, and 50Ti. The results of EDS analysis showed that both Ca and P deposited on the surfaces of all materials, after 20 days of immersion in SBF. Our in-vitro findings demonstrated that the 75Ti, 50Ti, and 25Ti composites have high potential to be used as load-bearing orthopedic materials.

摘要

具有增强机械性能和耐腐蚀性能的氧化铝-钛(AlO-Ti)复合材料最近已被开发出来,用于骨科和硬组织替代的潜在应用。然而,在任何临床应用之前,必须检查它们与生物环境的相互作用。因此,本研究的目的是评估三种钛体积百分比分别为25%、50%和75%的AlO-Ti复合材料的生物相容性。这些材料通过放电等离子烧结(SPS)制成,将MC3T3-E1细胞接种到样品盘上,以评估细胞活力、增殖、分化、矿化和黏附情况。此外,还分析了复合材料的磷灰石形成能力和润湿性。纯钛(100Ti)和整块氧化铝(0Ti)也通过SPS制备,并将复合材料的生物学特性与之进行比较。结果表明,与100Ti(42.7%)相比,75Ti(95.0%)、50Ti(87.3%)和25Ti(63.9%)的细胞活力更高。纯氧化铝也具有非常高的细胞活力(89.9%)。此外,50Ti在早期阶段细胞增殖较高,而暴露于75Ti的细胞在后期增殖更多。不同组之间的细胞分化大致相同,并随时间增加。复合材料表面的基质矿化高于0Ti和100Ti。此外,细胞在不同生物材料表面的黏附情况不同,在100Ti上发现更多纺锤形形态,在75Ti上观察到细胞略有增大,呈树突状形状并带有早期伪足,在0Ti、25Ti和50Ti上发现更多细胞增大且带有长树突状延伸。能谱分析(EDS)结果表明,在模拟体液(SBF)中浸泡20天后,钙和磷都沉积在所有材料的表面。我们的体外研究结果表明,75Ti、50Ti和25Ti复合材料具有作为承重骨科材料的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/c948c18eb3c8/bi-12-247-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/a69dfd435d42/bi-12-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/98a5d4cbb1cc/bi-12-247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/8a2714675a62/bi-12-247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/fbe7dc3618f8/bi-12-247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/40bff4a33997/bi-12-247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/668c335c52a8/bi-12-247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/18ce83a986dd/bi-12-247-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/78aa287ff4cc/bi-12-247-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/c948c18eb3c8/bi-12-247-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/a69dfd435d42/bi-12-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/98a5d4cbb1cc/bi-12-247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/8a2714675a62/bi-12-247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/fbe7dc3618f8/bi-12-247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/40bff4a33997/bi-12-247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/668c335c52a8/bi-12-247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/18ce83a986dd/bi-12-247-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/78aa287ff4cc/bi-12-247-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a7/9124877/c948c18eb3c8/bi-12-247-g009.jpg

相似文献

1
Osteoblastic cell response to AlO-Ti composites as bone implant materials.成骨细胞对作为骨植入材料的氧化铝-钛复合材料的反应。
Bioimpacts. 2022;12(3):247-259. doi: 10.34172/bi.2021.2330. Epub 2021 Sep 25.
2
In vivo performance of AlO-Ti bone implants in the rat femur.大鼠股骨中 AlO-Ti 骨植入物的体内性能。
J Orthop Surg Res. 2021 Jan 22;16(1):79. doi: 10.1186/s13018-021-02226-7.
3
Effect of calcium phosphate/bovine serum albumin coated AlO-Ti biocomposites on osteoblast response.钙磷/牛血清白蛋白涂层 AlO-Ti 生物复合材料对成骨细胞反应的影响。
Biomed Tech (Berl). 2024 Jan 23;69(4):367-382. doi: 10.1515/bmt-2023-0123. Print 2024 Aug 27.
4
Corrosion of AlO-Ti composites under inflammatory condition in simulated physiological solution.在模拟生理溶液中的炎症条件下 AlO-Ti 复合材料的腐蚀。
Mater Sci Eng C Mater Biol Appl. 2019 Sep;102:200-211. doi: 10.1016/j.msec.2019.04.047. Epub 2019 Apr 15.
5
Microstructure and biocompatibility of composite biomaterials fabricated from titanium and tricalcium phosphate by spark plasma sintering.采用火花等离子烧结法制备钛和磷酸三钙复合生物材料的微观结构与生物相容性。
J Biomed Mater Res A. 2013 May;101(5):1489-501. doi: 10.1002/jbm.a.34455. Epub 2012 Nov 7.
6
Osteoblastic cell behaviour on modified titanium surfaces.成骨细胞在改性钛表面的行为。
Micron. 2018 Feb;105:55-63. doi: 10.1016/j.micron.2017.11.010. Epub 2017 Nov 22.
7
AlO-Ti functionally graded material prepared by spark plasma sintering for orthopaedic applications.通过放电等离子烧结制备的用于骨科应用的铝钛功能梯度材料。
J Mech Behav Biomed Mater. 2017 Aug;72:82-89. doi: 10.1016/j.jmbbm.2017.04.024. Epub 2017 Apr 26.
8
In vitro and in vivo studies on zinc-hydroxyapatite composites as novel biodegradable metal matrix composite for orthopedic applications.锌羟基磷灰石复合材料作为新型可生物降解金属基复合材料在骨科应用中的体外和体内研究。
Acta Biomater. 2018 Apr 15;71:200-214. doi: 10.1016/j.actbio.2018.03.007. Epub 2018 Mar 9.
9
Osteoblastic cell behaviour on different titanium implant surfaces.成骨细胞在不同钛种植体表面的行为
Acta Biomater. 2008 May;4(3):535-43. doi: 10.1016/j.actbio.2007.12.002. Epub 2007 Dec 10.
10
Effect of calcium pyrophosphate on microstructural evolution and in vitro biocompatibility of Ti-35Nb-7Zr composite by spark plasma sintering.火花等离子烧结法对 Ti-35Nb-7Zr 复合材料微观结构演变及体外生物相容性的影响。
Mater Sci Eng C Mater Biol Appl. 2018 Sep 1;90:8-15. doi: 10.1016/j.msec.2018.04.042. Epub 2018 Apr 17.

引用本文的文献

1
In Vitro Biological Properties Assessment of 3D-Printed Hydroxyapatite-Polylactic Acid Scaffolds Intended for Bone Regeneration.用于骨再生的3D打印羟基磷灰石-聚乳酸支架的体外生物学性能评估
J Funct Biomater. 2025 Jun 12;16(6):218. doi: 10.3390/jfb16060218.
2
Multifunctional Hybrid Material for Endoprosthetic Implants Based on Alumina-Toughened Zirconia Ceramics and Additively Manufactured TiNbTa Alloys.基于氧化铝增韧氧化锆陶瓷和增材制造TiNbTa合金的用于内置假体植入物的多功能混合材料。
Materials (Basel). 2024 Apr 16;17(8):1838. doi: 10.3390/ma17081838.

本文引用的文献

1
Adaptation of MC3T3 cell line to Dulbecco's Modified Eagle's medium.MC3T3 细胞系适应杜尔贝科改良伊格尔培养基。
Tissue Cell. 2020 Jun;64:101341. doi: 10.1016/j.tice.2020.101341. Epub 2020 Jan 23.
2
Surface modification enhances interfacial bonding in PLLA/MgO bone scaffold.表面改性增强 PLLA/MgO 骨支架的界面结合。
Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110486. doi: 10.1016/j.msec.2019.110486. Epub 2019 Nov 23.
3
Thermal cycling effect on osteogenic differentiation of MC3T3-E1 cells loaded on 3D-porous Biphasic Calcium Phosphate (BCP) scaffolds for early osteogenesis.
热循环对加载于 3D 多孔双相磷酸钙(BCP)支架上的 MC3T3-E1 细胞早期成骨分化的影响。
Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110027. doi: 10.1016/j.msec.2019.110027. Epub 2019 Jul 26.
4
Corrosion of AlO-Ti composites under inflammatory condition in simulated physiological solution.在模拟生理溶液中的炎症条件下 AlO-Ti 复合材料的腐蚀。
Mater Sci Eng C Mater Biol Appl. 2019 Sep;102:200-211. doi: 10.1016/j.msec.2019.04.047. Epub 2019 Apr 15.
5
Highly porous PHB-based bioactive scaffolds for bone tissue engineering by in situ synthesis of hydroxyapatite.通过原位合成羟基磷灰石制备用于骨组织工程的高多孔 PHB 基生物活性支架。
Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:286-296. doi: 10.1016/j.msec.2019.03.014. Epub 2019 Mar 5.
6
Blood titanium level as a biomarker of orthopaedic implant wear.血钛水平作为骨科植入物磨损的生物标志物。
J Trace Elem Med Biol. 2019 May;53:120-128. doi: 10.1016/j.jtemb.2019.02.013. Epub 2019 Feb 28.
7
In Vitro Assessment of the Functional Dynamics of Titanium with Surface Coating of Hydroxyapatite Nanoparticles.羟基磷灰石纳米颗粒表面涂层钛的功能动力学体外评估
Materials (Basel). 2019 Mar 12;12(5):840. doi: 10.3390/ma12050840.
8
Promotion of osteogenic differentiation by non-thermal biocompatible plasma treated chitosan scaffold.非热生物相容等离子体处理壳聚糖支架促进成骨分化。
Sci Rep. 2019 Mar 6;9(1):3712. doi: 10.1038/s41598-019-40371-6.
9
What is the impact of titanium particles and biocorrosion on implant survival and complications? A critical review.钛颗粒和生物腐蚀性对种植体存活和并发症有什么影响?一项批判性综述。
Clin Oral Implants Res. 2018 Oct;29 Suppl 18:37-53. doi: 10.1111/clr.13305.
10
Synergistic effects of titania nanotubes and silicon to enhance the osteogenic activity.二氧化钛纳米管和硅协同作用增强成骨活性。
Colloids Surf B Biointerfaces. 2018 Nov 1;171:419-426. doi: 10.1016/j.colsurfb.2018.07.052. Epub 2018 Jul 25.